Brian Joseph, Kelly A. Marshall, Peter Harley, Jacob R. Mann, Francesco Alessandrini, Carlos G. Vanoye, Wanhao Chi, Mercedes Prudencio, Dina Simkin, Tzu‐Ting Kao, Reshma R. Desai, Matthew J. Keuss, Simone Barattucci, Matteo Zanovello, Puja R. Mehta, Jean-Marc DeKeyser, Francesco Limone, Jonathan Lee, Anna‐Leigh Brown, Marcel F. Leyton-Jaimes, Leslie A. Nash, Irune Guerra San Juan, Eleonora Aronica, Brian J. Wainger, Mala M. Shah, Anand Goswami, Neil A. Shneider, Dennis W. Dickson, Juan Burrone, Chaolin Zhang, Hynek Wichterle, Leonard Petrucelli, Jonathan K. Watts, Alfred L. George, Pietro Fratta, Kevin Eggan, Evangelos Kiskinis
Motor neuron hyperexcitability is a broadly observed yet poorly understood feature of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Nuclear depletion and cytoplasmic aggregation of the RNA splicing protein TAR DNA-binding protein 43 (TDP-43) are observed in most ALS and FTD patients. Here we show that TDP-43 dysfunction causes mis-splicing of KCNQ2, which encodes a voltage-gated potassium channel (Kv7.2) that regulates neuronal excitability. Using iPSC-derived neurons and postmortem ALS/FTD brain and spinal cord tissue we find widespread, disease-specific and TDP-43-specific skipping of an exon encoding the KCNQ2 pore domain. The mis-spliced mRNA escapes degradation and is translated into a nonfunctional protein with severely reduced ion conductance that aggregates in the endoplasmic reticulum and causes intrinsic hyperexcitability in ALS neuronal models. This event, which correlates with higher phosphorylated TDP-43 levels and earlier age of disease onset in patients, can be rescued by splice-modulating antisense oligonucleotides that dampen hyperexcitability in induced pluripotent stem cell cortical neurons and spinal motor neurons with TDP-43 depletion. Our work reveals that nuclear TDP-43 maintains the fidelity of KCNQ2 expression and function and provides a mechanistic link between established excitability disruption in ALS/FTD patients and TDP-43 dysfunction. TDP-43 dysfunction in ALS/FTD causes faulty splicing of the KCNQ2 ion channel, leading to toxic protein buildup, neuron hyperactivity and a potential new biomarker and treatment target using RNA-based therapies.